NCT05041920View on ClinicalTrials.gov

A Drug-drug Interaction Study of Famitinib Malate With a Proton Pump Inhibitor in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 7, 2021

Primary Completion Date

October 6, 2021

Study Completion Date

October 27, 2021

Conditions
Tumor
Interventions
DRUG

famitinib、omeprazole

famitinib malate, 25 mg on study day 1; omeprazole, 40 mg, qd on study day 10-14, 16-22; famotine malate together with omeprazole, on study day 15.

Trial Locations (1)

210009

Zhongda Hospital, Affiliated to Southest University, Nanjing

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT05041920 - A Drug-drug Interaction Study of Famitinib Malate With a Proton Pump Inhibitor in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter